Inhibition of TNFα production and blocking of mitogen-activated protein kinase/NFκB activation in lipopolysaccharide-induced thp-1 human monocytes by 3-o-acetyl-11-keto-β-boswellic acid

Journal of Food Lipids

Volumn 16, Issue 3, 2009, Pages 325-344

  Sengupta, Krishanu ^a   Golakoti, Trimurtulu ^a   Marasetti, Ajit K ^a   Tummala, Tejaswi ^a   Ravada, Suryachandra R ^a   Krishnaraju, Alluri V ^a   Raychaudhuri, Siba P ^b  

^a Laila Impex R and D Centre   (India)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSWELLIA; BOSWELLIA SERRATA;

EID: 68849118134     PISSN: 10657258     EISSN: 17454522     Source Type: Journal    
DOI: 10.1111/j.1745-4522.2009.01150.x     Document Type: Article

References (49)

1. ABRAMOVITZ, M., WONG, E., COX, M.E., RICHARDSON, C.D., LI, C. Vickers, P.J. 1993. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur. J. Biochem. 215, 105 111.
2. AIKAWA, Y., YAMAMOTO, M., YAMAMOTO, T. TANAKA, K. 2002. An antirheumatic agent T-614 inhibits NFκB activation in LPS- and TNFα-stimulated THP-1 cells without interfering with IκB degradation. Inflamm. Res. 51, 188 194.
3. AMMON, H.P., SAFAYHI, H., MACK, T. SABIERAJ, J. 1993. Mechanism of anti-inflammatory actions of curcumin and boswellic acids. J. Ethnopharmacol. 38, 113 119.
4. BHARTI, A.C., DONATO, N., SINGH, S. AGGARWAL, B.B. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kB and IκBa kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053 1062.
5. BRUNET, A. POUYSSEGUR, J. 1997. Mammalian MAP kinase modules: How to transduce specific signals. Essays Biochem. 32, 1 16.
6. DETMERS, P.A., ZHOU, D., POLIZZI, E., THIERINGER, R., HANLON, W.A., VAIDYA, S. BANSAL, V. 1998. Role of stress activated mitogen-activated protein kinase (p38) in beta 2-integrin dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J. Immunol. 161, 1921 1929.
7. DIXON, R.A., DIEHL, R.E., OPAS, E., RANDS, E., VICKERS, P.J., EVANS, J.F., GILLARD, J.W. MILLER, D.K. 1990. Requirement of a 5-lipoxygenase- activating protein for leukotriene synthesis. Nature 343, 282 284.
8. ESTROV, Z., SHISHODIA, S., FADERL, S., HARRIS, D., VAN, Q., KANTARJIAN, H.M., TALPAZ, M. AGGARWAL, B.B. 2003. Resveratrol blocks interleukin-1beta- induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102, 987 995.
9. EVANS, J.F., FERGUSON, A.D., MOSLEY, R.T. HUTCHINSON, J.H. 2008. What's all the FLAP about? 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol. Sci. 29, 72 78.
10. GAYATHRI, B., MANJULA, N., VINAYKUMAR, K.S., LAKSHMI, B.S. BALAKRISHNAN, A. 2007. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases. Int. Immunopharmacol. 7, 473 482.
11. GOKARAJU, G., GOKARAJU, R., GOTTUMUKKALA, V.S., GOLAKOTI, T. PRATHA, S. 2004. Process for producing a fraction enriched up to 100% 3-O-acetyl-11-keto- beta boswellic acid from an extract containing a mixture of boswellic acid. US Patent application # 20040073060.
12. GUPTA, I., PARIHAR, A., MALHOTRA, P., SINGH, G.B., LUDTKE, R., SAFAYHI, H. AMMON, H.P. 1997. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 2, 37 43.
13. GUPTA, I., GUPTA, V., PARIHAR, A., GUPTA, S., LUDTKE, R., SAFAYHI, H. AMMON, H.P. 1998. Effect of Boswellia serrata gum resin in patients with bronchial asthma: Results of double blind, placebo controlled, 6-week clinical study. Eur. J. Med. Res. 3, 511 514.
14. GUPTA, I., PARIHAR, A., MALHOTRA, P., GUPTA, S., LUDTKE, R., SAFAYHI, H. AMMON, H.P. 2001. Effect of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 67, 391 395.
15. HAWIGER, J., VEACH, R.A., LIU, X.Y., TIMMONS, S. BALLARD, D.W. 1999. IκB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Blood 94, 1711 1716.
16. KAPIL, A. MOZA, N. 1992. Anticomplementary activity of boswellic acids-an inhibitor of C3-convertase of the classical complement pathway. Int. J. Immunopharmacol. 14, 1139 1143.
17. KARIN, M. 2005. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2, 386 390.
18. KARIN, M. BEN-NERIAH, Y. 2000. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621 663.
19. KIMMATKAR, N., THAWANI, V., HINGORANI, I. KHIYANI, R. 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-A randomized double blind placebo controlled trial. Phytomedicine 10, 3 7.
20. LAWRENCE, T., GILROY, D.W., COLVILLE-NASH, P.R. WILLOUGHBY, D.A. 2001. Possible new role for NF kappaB in the resolution of inflammation. Nature Med. 7, 1291 1297.
21. MANCINI, J.A., ABRAMOVITZ, M., COX, M.E., WONG, E., CHARLESON, S., PERRIER, H., WANG, Z., PRASIT, P. VICKERS, P.J. 1993. 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318, 277 281.
22. MINDEN, A. KARIN, M. 1997. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333, F85 F104.
23. MOUSSAIEFF, A., SHOHAMI, E., KASHMAN, Y., FRIDE, E., SCHMITZ, M.L., RENNER, F., FIEBICH, B.L., MUNOZ, E., BEN-NERIAH, Y. MECHOULAM, R. 2007. Incensole acetate, a novel anti inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol. Pharmacol. 72, 1657 1664.
24. NICK, J.A., AVDI, N.J., GERWINS, P., JOHNSON, G.L. WORTHEN, G.S. 1996. Activation of a p38 mitogen activated protein kinase in human neutrophils by lopopolysaccharide. J. Immunol. 156, 4867 4875.
25. NICK, J.A., AVDI, N.J., YOUNG, S.K., LEHMAN, L.A., MCDONALD, P.P., FRASCH, S.C., BILLSTROM, M.A., HENSON, P.M., JOHNSON, G.L. WORTHEN, G.S. 1999. Selective-activation and functional significance of p38a mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. Clin. Invest. 103, 851 858.
26. NICK, J.A., YOUNG, S.K., BROWN, K.K., AVDI, N.J., ARNDT, P.G., SURATT, B.T., JANES, M.S., HENSON, P.M. WORTHEN, G.S. 2000. Role of p38 MAP kinase in a murine model of pulmonary inflammation. J. Immunol. 164, 2151 2159.
27. O'CONNELL, M.A., BENNETT, B.L., MERCURIO, F., MANNING, A.M. MACKMAN, N. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 273, 30410 30414.
28. ONO, K. HAN, J. 2000. The p38 signal transduction pathway: Activation and function. Cell Signal. 12, 1 13.
29. PERKINS, N.D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nature Rev. Mol. Cell Biol. 8, 49 62.
30. QI, M. ELION, E.A. 2005. MAP kinase pathways. J. Cell Sci. 118, 3569 3572.
31. REDDANNA, P., WHELAN, J., MADDIPATI, K.R. CHANNA REDDY, C. 1990. Purification of arachidonate 5-lipoxygenase from potato tuber. Methods Enzymol. 187, 268 277.
32. REDDY, G.K., CHANDRAKASAN, G. DHAR, S.C. 1989. Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem. Pharmacol. 38, 3527 3534.
33. ROUX, P.P. BLENIS, J. 2004. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320 344.
34. ROY, S., KHANNA, S., SHAH, H., RINK, C., PHILLIPS, C., PREUSS, H.G., SUBBARAJU, G.V., TRIMURTULU, G., KRISHNARAJU, A.V., BAGCHI, M. ET AL. 2005. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in micro vascular endothelial cells. DNA Cell Biol. 24, 244 255.
35. ROY, S., KHANNA, S., KRISHNARAJU, A.V., SUBBARAJU, G.V., YASMIN, T., BAGCHI, D. SEN, C.K. 2006. Regulation of vascular responses to inflammation: Inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to anti-inflammatory Boswellia. Antioxid. Redox Signal. 3&4, 653 660.
36. SAFAYHI, H., MACK, T., SABIERAJ, J., ANAZODO, M.I., SUBRAMANIAN, L.R. AMMON, H.P. 1992. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261, 1143 1146.
37. SAFAYHI, H., SAILER, E.R. AMMON, H.P. 1995. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol. Pharmacol. 47, 1212 1216.
38. SAFAYHI, H., RALL, B., SAILER, E.R. AMMON, H.P. 1997. Inhibition by boswellic acids of human leukocyte elastase. J. Pharmacol. Exp. Ther. 281, 460 463.
39. SAILER, E.R., SUBRAMANIAN, L.R., RALL, B., HOERNLEIN, R.F., AMMON, H.P.T. SAFAYHI, H. 1996. Acetyl-11-keto-beta-boswellic acid: Structure requirement for binding and 5-lipoxygenase inhibitory activity. Brit. J. Pharmacol. 117, 615 618.
40. SAMUELSSON, B. 1983. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568 575.
41. SAMUELSSON, B., DAHLE'N, S.E., LINDGREN, J.Å., ROUZER, C.A. SERHAN, C.N. 1987. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237, 1171 1176.
42. SENGUPTA, K., HERNÁNDEZ-RAMÍREZ, V.I., RIOS, A., MONDRAGÓN, R. TALAMÁS-ROHANA, P. 2001. Entamoeba histolytica: Monoclonal antibody against the beta1 integrin-like molecule (140 kDa) inhibits cell adhesion to extracellular matrix components. Exp. Parasitol. 98, 83 89.
43. SENGUPTA, K., BANERJEE, S., DHAR, K., SAXENA, N.K., MEHTA, S., CAMPBELL, D.R. BANERJEE, S.K. 2006. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Cα-mediated breast tumor cell proliferation. Biochemistry 45, 10698 10709.
44. SHISHODIA, S., MAJUMDAR, S., BANERJEE, S. AGGARWAL, B.B. 2003. Ursolic acid inhibits nuclear factor-kB activation induced by carcinogenic agents through suppression of IκBa kinase and p65 phosphorylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63, 4375.
45. SYROVETS, T., BÜCHELE, B., KRAUSS, C., LAUMONNIER, Y. SIMMET, T. 2005. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. J. Immunol. 174, 498 506.
46. TAK, P.P. FIRESTEIN, G.S. 2001. NF-kappaB: A key role in inflammatory diseases. J. Clin. Invest. 107, 7 11.
47. TAKADA, Y. AGGARWAL, B.B. 2003. Betulinic acid suppresses carcinogen induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J. Immunol. 171, 3278.
48. TAKADA, Y., ICHIKAWA, H., BADMAEV, V. AGGARWAL, B.B. 2006. Acetyl-11-keto-β-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-κB and NF-κB-regulated gene expression. J. Immunol. 176, 3127 3140. (Pubitemid 43306975)
49. ZU, Y.L., QI, J., GILCHRIST, A., FERNANDEZ, G.A., VAZQUEZ-ABAD, D., KREUTZER, D.L., HUANG, C.K. SHA'AFI, R.I. 1998. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J. Immunol. 160, 1982 1989.